<?xml version="1.0"?>
<trials subjects="1">
  <Triall>
    <main>
      <UTRN />
      <trial_id>ChiCTR1800015716</trial_id>
      <utrn />
      <reg_name>ChiCTR</reg_name>
      <date_registration>2018-03-08</date_registration>
      <primary_sponsor>The Second Affiliated Hospital of Army Medical University </primary_sponsor>
      <public_title>A clinical study of long acting CSF VS short acting CSF in the mobilization of healthy donors in allogeneic hematopoietic stem cell transplantation </public_title>
      <acronym />
      <scientific_title>The effect of long acting CSF VS short acting  CSF in the mobilization of healthy donors in allogeneic hematopoietic stem cell transplantation A Multicenter,Randomized controlled trial  </scientific_title>
      <Scientific_acronym />
      <date_enrolment>2018-03-01</date_enrolment>
      <type_enrolment />
      <target_size>Test group:97;Control group:97;</target_size>
      <recruitment_status>Recruiting</recruitment_status>
      <url>http://www.chictr.org.cn/showproj.aspx?proj=25876</url>
      <study_type>Interventional study</study_type>
      <study_design>Randomized parallel controlled trial</study_design>
      <phase>New Treatment Measure Clinical Study</phase>
      <hc_freetext>Mobilization of healthy donors for allogeneic hematopoietic stem cell transplantation </hc_freetext>
      <i_freetext>Test group:long acting G-CSF d1;Control group:short acting G-CSF 10ug/kg d1-4;</i_freetext>
      <results_actual_enrolment />
      <results_date_completed />
      <results_url_link />
      <results_summary />
      <results_date_posted />
      <results_date_first_publication />
      <results_baseline_char />
      <results_participant_flow />
      <results_adverse_events />
      <results_outcome_measures />
      <results_url_protocol />
      <results_IPD_plan />
      <results_IPD_description />
    </main>
    <contacts>
      <contact>
        <type>Scientific</type>
        <firstname>Gao Li</firstname>
        <middlename />
        <lastname />
        <address>83 Xinqiao Main Street, Shapingba District, Chongqing, China</address>
        <city />
        <country1 />
        <zip />
        <telephone>+86 13228686076</telephone>
        <email>gaotiantiantiger@163.com</email>
        <affiliation>The Second Affiliated Hospital of Army Medical University </affiliation>
      </contact>
      <contact>
        <type>Public</type>
        <firstname>Zhang Xi</firstname>
        <middlename />
        <lastname />
        <address>83 Xinqiao Main Street, Shapingba District, Chongqing, China</address>
        <city />
        <country1 />
        <zip />
        <telephone>+86 023-68774509</telephone>
        <email>zhangxxi@126.com</email>
        <affiliation>The Second Affiliated Hospital of Army Medical University</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>China</country2>
    </countries>
    <criteria>
      <inclusion_criteria>1) relationship between allogeneic hematopoietic stem cell transplantation of healthy donors;
2) aged 18-55 years;
3) weight 50-100Kg;
4) normal heart function;
5) normal liver and kidney function;
6) hepatitis index examination negative;
7) detection of cytomegalovirus negative;
8) normal ECG;
9) ultrasound of abdomen, chest normal;
10) Voluntary participants, informed consent. </inclusion_criteria>
      <agemin>18</agemin>
      <agemax>55</agemax>
      <gender>Both</gender>
      <exclusion_criteria>1) Uncontrolled active infection;
2) unrelated allogeneic hematopoietic stem cell transplantation;
3) HIV antibody, syphilis antibody positive;
4) with allergic diseases or allergies, or of the goods or other genetically engineered Escherichia coli derived from biological products allergy;
5) serious spirit or nervous system disorders, effects of informed consent and/or adverse reaction statement or observation;
6) in lactation.                   </exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code />
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword />
    </health_condition_keyword>
    <intervention_code>
      <i_code>;;</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword />
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>leukocyte;hemoglobin;Platelet;Mononuclear cells;CD34+ cells;</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome>T cell subgroup;B cell subgroup;GFU-GM;Reconstructive time of leukocyte;Reconstructive time of platele;the ratio of GVHD;headache;bone pain;fever;muscle pain;liver damage;renal damage;Splenomegaly;the ratio of relapse;Hospitalization expenses;</sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name />
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id />
        <issuing_authority />
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>National Nature Science Fund 81500147</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2018-04-06</approval_date>
        <contact_name>Taixiang Wu</contact_name>
        <contact_address>37 Guo Xue Xiang, Chengdu, Sichuang, China</contact_address>
        <contact_phone />
        <contact_email />
      </ethics_review>
    </ethics_reviews>
  </Triall>
</trials>